Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnXnet was a medical technology company primarily focused on the development and commercialization of safety-engineered medical devices. Its flagship technology was the "Smart Needle," a retractable needle system designed to prevent accidental needlestick injuries and the transmission of blood-borne pathogens such as HIV and Hepatitis. The company aimed to integrate this technology into various medical applications, including syringes, blood collection sets, and IV catheters. While it sought to address a significant market driven by the Needlestick Safety and Prevention Act of 2000, the company struggled with long-term commercial viability and is currently inactive.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnXnet.